These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 32118020)
1. Improving Patient Involvement in the Lifecycle of Medicines: Insights From the EUPATI BE Survey. Grine L; Janssens R; van Overbeeke E; Derijcke D; Silva M; Delys B; Dusart I; Aertsen V; Mertens de Wilmars M; Robaczewska J; Stevens H Front Med (Lausanne); 2020; 7():36. PubMed ID: 32118020 [TBL] [Abstract][Full Text] [Related]
2. The Role of EUPATI CH in Promoting Patient Involvement in Clinical Research: A Multi-Stakeholder Research Project. Sessa C; Schmid C; Tolotti A; Magnin A; Haerry D; Bonetti L; Klingmann I Front Med (Lausanne); 2021; 8():795659. PubMed ID: 35004770 [No Abstract] [Full Text] [Related]
3. The Launch of the European Patients' Academy on Therapeutic Innovation in the Netherlands: A Qualitative Multi-Stakeholder Analysis. van Rensen A; Voogdt-Pruis HR; Vroonland E Front Med (Lausanne); 2020; 7():558. PubMed ID: 33072776 [No Abstract] [Full Text] [Related]
4. EUPATI Guidance for Patient Involvement in Medicines Research and Development (R&D); Guidance for Pharmaceutical Industry-Led Medicines R&D. Warner K; See W; Haerry D; Klingmann I; Hunter A; May M Front Med (Lausanne); 2018; 5():270. PubMed ID: 30356834 [TBL] [Abstract][Full Text] [Related]
5. Patient Involvement in the Lifecycle of Medicines According to Belgian Stakeholders: The Gap Between Theory and Practice. Janssens R; van Overbeeke E; Verswijvel L; Meeusen L; Coenegrachts C; Pauwels K; Dooms M; Stevens H; Simoens S; Huys I Front Med (Lausanne); 2018; 5():285. PubMed ID: 30364285 [No Abstract] [Full Text] [Related]
6. EUPATI and Patients in Medicines Research and Development: Guidance for Patient Involvement in Ethical Review of Clinical Trials. Klingmann I; Heckenberg A; Warner K; Haerry D; Hunter A; May M; See W Front Med (Lausanne); 2018; 5():251. PubMed ID: 30246010 [TBL] [Abstract][Full Text] [Related]
7. EUPATI and Patients in Medicines Research and Development: Guidance for Patient Involvement in Regulatory Processes. Haerry D; Landgraf C; Warner K; Hunter A; Klingmann I; May M; See W Front Med (Lausanne); 2018; 5():230. PubMed ID: 30175100 [TBL] [Abstract][Full Text] [Related]
8. Patient-Oriented Research Competencies in Health (PORCH) for patients, healthcare providers, decision-makers and researchers: protocol of a scoping review. Mallidou AA; Frisch N; Doyle-Waters MM; MacLeod MLP; Ward J; Atherton P Syst Rev; 2018 Jul; 7(1):101. PubMed ID: 30025543 [TBL] [Abstract][Full Text] [Related]
9. EUPATI Guidance for Patient Involvement in Medicines Research and Development: Health Technology Assessment. Hunter A; Facey K; Thomas V; Haerry D; Warner K; Klingmann I; May M; See W Front Med (Lausanne); 2018; 5():231. PubMed ID: 30238004 [TBL] [Abstract][Full Text] [Related]
10. Acceptability and Perceived Benefits and Risks of Public and Patient Involvement in Health Care Policy: A Delphi Survey in Belgian Stakeholders. Cleemput I; Christiaens W; Kohn L; Léonard C; Daue F; Denis A Value Health; 2015 Jun; 18(4):477-83. PubMed ID: 26091602 [TBL] [Abstract][Full Text] [Related]
11. Varying viewpoints of Belgian stakeholders on models of interhospital collaboration. De Regge M; De Pourcq K; Gemmel P; Van de Voorde C; Van den Heede K; Eeckloo K BMC Health Serv Res; 2018 Dec; 18(1):942. PubMed ID: 30514304 [TBL] [Abstract][Full Text] [Related]
12. Patient Engagement Practices in Clinical Research among Patient Groups, Industry, and Academia in the United States: A Survey. Smith SK; Selig W; Harker M; Roberts JN; Hesterlee S; Leventhal D; Klein R; Patrick-Lake B; Abernethy AP PLoS One; 2015; 10(10):e0140232. PubMed ID: 26465328 [TBL] [Abstract][Full Text] [Related]
13. Fostering innovation through stakeholders' engagement at the healthcare industry: Tapping the right key. Segarra-Oña M; Peiró-Signes Á; Verma R Health Policy; 2020 Aug; 124(8):895-901. PubMed ID: 32522366 [TBL] [Abstract][Full Text] [Related]
14. Prioritising target behaviours for research in diabetes: Using the nominal group technique to achieve consensus from key stakeholders. Mc Sharry J; Fredrix M; Hynes L; Byrne M Res Involv Engagem; 2016; 2():14. PubMed ID: 29062515 [TBL] [Abstract][Full Text] [Related]
15. Sustaining Meaningful Patient Engagement Across the Lifecycle of Medicines: A Roadmap for Action. Cavaller-Bellaubi M; Faulkner SD; Teixeira B; Boudes M; Molero E; Brooke N; McKeaveney L; Southerton J; Vicente MJ; Bertelsen N; García-Burgos J; Pirard V; Reid K; Ferrer E Ther Innov Regul Sci; 2021 Sep; 55(5):936-953. PubMed ID: 33970465 [TBL] [Abstract][Full Text] [Related]
16. A tall order on a tight timeframe: stakeholder perspectives on comparative effectiveness research using electronic clinical data. Holve E; Lopez MH; Scott L; Segal C J Comp Eff Res; 2012 Sep; 1(5):441-51. PubMed ID: 24236421 [TBL] [Abstract][Full Text] [Related]
17. Enabling Transdisciplinary Collaboration: Stakeholder Views on Working With "Children With Mentally Ill Parents" Research Groups. Kaisler RE; Grill C Front Psychiatry; 2021; 12():760716. PubMed ID: 34887787 [TBL] [Abstract][Full Text] [Related]
18. The Effectiveness of Integrated Care Pathways for Adults and Children in Health Care Settings: A Systematic Review. Allen D; Gillen E; Rixson L JBI Libr Syst Rev; 2009; 7(3):80-129. PubMed ID: 27820426 [TBL] [Abstract][Full Text] [Related]
19. Missed opportunities for impact in patient and carer involvement: a mixed methods case study of research priority setting. Snow R; Crocker JC; Crowe S Res Involv Engagem; 2015; 1():7. PubMed ID: 29062496 [TBL] [Abstract][Full Text] [Related]